Ken Griffin Synaptogenix, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding SNPX
# of Institutions
2Shares Held
30.3KCall Options Held
0Put Options Held
0About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $26M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...